Combination therapy can prevent cytostatic resistance

Researchers at Karolinska Institutet have found a new way of preventing resistance to cytostatics used in the treatment of cancers such as medulloblastoma, the most common form of malignant brain tumour in children. The promising ...

Nov 26, 2015
popularity32 comments 0

Impact of recurrence score assay varies with patient age

(HealthDay)—For women with early-stage breast cancer, the impact of receipt of the 21-gene recurrence score (RS) assay varies with patient age, according to a study published online Nov. 23 in the Journal of Clinical Oncology.

Nov 25, 2015
popularity1 comments 0

Promising drug combination for advanced prostate cancer

A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals ...

Nov 25, 2015
popularity9 comments 0

Scientists identify promising new melanoma drug

A new drug discovered by scientists at Sanford Burnham Prebys Medical Discovery Institute (SBP) may show promise for treating skin cancers that are resistant or unresponsive to today's leading therapies.

Nov 25, 2015
popularity8 comments 0

Portrazza approved for advanced lung cancer

(HealthDay)—Portrazza (necitumumab), in combination with two other chemotherapy drugs, has been approved by the U.S. Food and Drug Administration to treat advanced squamous non-small cell lung cancer, the agency said Tuesday ...

Nov 25, 2015
popularity3 comments 0